menu
    • menu

    Company profile for Ripple Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ripple Therapeutics is the therapeutics/drug delivery spin out of Interface Biologics, Inc. (IBI) after the sale of its surface modification business to Evonik (ETR:EFK) was completed.Our lead product (IBE-814 IVT) is a fully degradable intravitreal dexamethasone prodrug implant targeting DME, RVO and NIU indications. Our target product profile is zero-order drug release for 6-9 months with a 30G needle and 1/10th the loading ...
    Ripple Therapeutics is the therapeutics/drug delivery spin out of Interface Biologics, Inc. (IBI) after the sale of its surface modification business to Evonik (ETR:EFK) was completed.Our lead product (IBE-814 IVT) is a fully degradable intravitreal dexamethasone prodrug implant targeting DME, RVO and NIU indications. Our target product profile is zero-order drug release for 6-9 months with a 30G needle and 1/10th the loading of the leading commercial IVT product which suggests a potential to reduce steroid related cataract and IOP AEs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ripple TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    MaRS Center, South Tower 101 College Street, Suite 300 Toronto, ON, M5G 1L7
    Telephone
    Telephone
    (416) 673-8170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rippletherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ripple-therapeutics/?originalSubdomain=ca
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos
    Ripple Therapeutics Announces Evaluation and Licensing Agreements with Glaukos

    15 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/930509/ripple-therapeutics-announces-evaluation-and-licensing-agreements-with-glaukos

    ACCESSWIRE
    15 Oct 2024
    Share Share
    Ripple Therapeutics Collaborates AbbVie To Develop Next-Gen Glaucoma Therapies
    Ripple Therapeutics Collaborates AbbVie To Develop Next-Gen Glaucoma Therapies

    17 Sep 2024

    // ACCESSWIRE

    https://www.accesswire.com/918653/ripple-therapeutics-announces-collaboration-and-option-to-license-agreement-with-abbvie-to-develop-next-generation-therapies-for-glaucoma-management

    ACCESSWIRE
    17 Sep 2024
    Share Share
    Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform
    Hovione and Ripple Enter Strategic Partnership to Expand Epidel Platform

    20 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hovione-and-ripple-enter-strategic-partnership-to-expand-epidel-platform-into-non-ophthalmic-space-301776009.html

    PR NEWSWIRE
    20 Mar 2023
    Share Share
    Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors
    Ripple Therapeutics Appoints Jonathan Talamo, M.D., to Board of Directors

    05 May 2021

    // ACCESSWIRE

    https://www.accesswire.com/643644/Ripple-Therapeutics-Appoints-Jonathan-Talamo-MD-to-Board-of-Directors

    ACCESSWIRE
    05 May 2021
    Share Share
    Ripple Announces First Patient Treated in Phase II Trial Evaluating IBE-814
    Ripple Announces First Patient Treated in Phase II Trial Evaluating IBE-814

    20 Apr 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/ripple-therapeutics-announces-first-patient-treated-in-phase-ii-trial-evaluating-ibe-814-ivt-in-dme-and-rvo/

    BIOSPACE
    20 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search